Advertisement

Topics

Tetra Bio-Pharma Inc.: Tetra Bio-Pharma Announces FDA Orphan Drug Designation for PPP001 in Treatment of Complex Regional Pain Syndrome

06:04 EDT 14 Mar 2018 | FinanzNachrichten

OTTAWA, ONTARIO -- (Marketwired) -- 03/14/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced that the U.S. Food and Drug Administration (FD...

Original Article: Tetra Bio-Pharma Inc.: Tetra Bio-Pharma Announces FDA Orphan Drug Designation for PPP001 in Treatment of Complex Regional Pain Syndrome

NEXT ARTICLE

More From BioPortfolio on "Tetra Bio-Pharma Inc.: Tetra Bio-Pharma Announces FDA Orphan Drug Designation for PPP001 in Treatment of Complex Regional Pain Syndrome"

Advertisement
Quick Search
Advertisement
Advertisement